Results 41 to 50 of about 49,301 (186)
International Journal of Cancer, EarlyView.What's New? While the effectiveness of systemic anticancer therapy is well documented, it commonly causes severe toxicity. This study of the 467 systemic anticancer therapy agents currently approved globally for clinical and/or research purposes found that peripheral neurotoxicity is associated with 45% of classical chemotherapies, 21% of targeted ...
Cassie Higgins +3 more
wiley +1 more source
Case Reports in Neurological Medicine, 2013 Guillain-Barré syndrome is an immune-mediated polyneuropathy that frequently presents with progressive muscle weakness. Hyponatremia has recently been described as a feature of this condition, generally appearing over the course of the illness and ...
Benjamin Kloesel, LaTonya J. Hickson
doaj +1 more source
Isolated right ventricular Takotsubo cardiomyopathy in Guillain–Barré syndrome
BMC Cardiovascular Disorders, 2022 Background Takotsubo cardiomyopathy can present itself in the most varied clinical forms, with extremely variable electrocardiogram anomalies and presence of comorbidities with a significant systemic commitment.
Xiaojing Song +3 more
doaj +1 more source
Guillain-Barré syndrome in a child: a clinical case
Alʹmanah Kliničeskoj Mediciny, 2020 Guillain-Barré syndrome is an orphan autoimmune disease associated with the involvement of the peripheral nervous system. The clinical course of the syndrome has four main types. We present a clinical case of Guillain-Barré syndrome in a 6-year old child.
A. Yu. Ryabchenko, E. V. Grankin
doaj +1 more source
Guillain-Barré syndrome with transition from hashimoto's to graves' disease: a case report
BMC Endocrine Disorders, 2022 Background On rare occasions, there can be a transition from Hashimoto's to Graves' disease. However, there are no reported cases of transition from Hashimoto's to Graves' disease triggered by the onset of Guillain-Barré syndrome.
Mari Asano, Tsuneaki Kenzaka
doaj +1 more source
Journal of Education and Teaching in Emergency Medicine, 2018 Audience: This scenario was developed to educate emergency medicine residents on the diagnosis and management of Guillain-Barré syndrome in the emergency department.
Jennifer Yee, DO +2 more
doaj +1 more source
Nutrition in Clinical Practice, EarlyView.Abstract Background This study aimed to develop and assess a bedside nasojejunal tube placement technique designed for resource‐limited settings to address the specific challenges of enteral nutrition (EN) delivery in neurocritical care patients, particularly those at high risk of reflux and aspiration. The technique sought to overcome the drawbacks of
Niuchenglin +5 more
wiley +1 more source
A rare form of Guillain-Barré syndrome: pharyngeal-cervical-brachial variant
The Turkish Journal of Pediatrics, 2008 Guillain-Barré syndrome is clinically characterized by acute onset of generalized, symmetrical, and ascending muscle weakness and areflexia from peripheral nerve involvement. In Guillain-Barré syndrome variants, however, some patients have unusual
M Ozlem Hergüner +3 more
doaj
High doses of immunoglobulin g in the therapy for severe forms of myasthenia gravis and Guillain-Barré syndrome [PDF]
Vojnosanitetski Pregled, 2006 Background/Aim. High doses of immunoglobulin G (IVIG) have been recognized as a very important therapeutic modality in the treatment of neurological diseases.
Lavrnić Dragana +9 more
doaj +1 more source
SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms
Frontiers in Immunology, 2021 Since December 2019, the world has been facing an outbreak of a new disease called coronavirus disease 2019 (COVID-19). The COVID-19 pandemic is caused by a novel beta-coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Shahrzad Shoraka +4 more
doaj +1 more source